NEA Partners 14, L.P.
CIK 1551531 · last filed 2020-03-10
NEA Partners 14, L.P. is a corporate insider who has filed 12 SEC Form 4 insider transactions across 6 companies since 2017. The most recent filing, for CSBR, was dated Mar 10, 2020. Across all open-market trades the lifetime net is +$140.0M, making them a net buyer over the disclosed history. Current disclosed insider exposure totals $150.2M across reported positions. The firm reports its address in Timonium, MD. 70 SEC filings were submitted jointly with NEA 14 GP, LTD.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Charts
Trading activity, where the exposure sits, and each trade against the stock price.
OYST price and trades
Daily close with each Form 4 filing on this company marked: green = open-market buy, red = open-market sale, purple = grants, exercises, gifts and other non-market transactions. Marker size scales with the dollar value.
Shares held
Shares owned after each reported transaction on this company (direct holdings as reported).
Open-market buying and selling
by monthDollar value of open-market purchases (code P, up) and sales (code S, down) across all companies, by filing month. Grants, exercises and gifts are excluded.
Exposure by company
latestMost recently reported shares × current price. Faded bars (*) have had no filing in 3 years, so the person may no longer hold them. Click a bar to chart that company.
Filer Profile
SUITE 600
TIMONIUM, MD 21093
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| CSBR | 10%+ Owner | 1,713,720 | $4.86 | $8.33M | -$39.60M | 1 | 2020-03-10 |
| Oyster Point Pharma, Inc. (OYST) Delisted | 10%+ Owner | 3,928,740 | $11.17 | $43.88M | $134.64M | 1 | 2019-11-04 |
| APPN | 10%+ Owner | 2,751,444 | $51.57 | $141.89M | $0 | 1 | 2018-02-15 |
| SYNLOGIC, INC. (SYBX) Delisted | 10%+ Owner | 281,929 | $0.69 | $194.5K | $0 | 2 | 2018-01-26 |
| Mersana Therapeutics, Inc. (MRSN) Delisted | 10%+ Owner | 325,606 | $29.08 | $9.47M | $45.00M | 1 | 2017-07-06 |
| MULESOFT, INC (MULE) Delisted | 10%+ Owner | 12,679,970 | — | — | $0 | 1 | 2017-03-22 |
Recent Filings
12 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2020-03-10 | CSBR | Mixed | +1,209,760 | -$28 | EDGAR |
| 2019-11-04 | Oyster Point Pharma, Inc. (OYST) Delisted | Mixed | +50,425,461 | $134.64M | EDGAR |
| 2018-03-27 | — | Buy (P) | +2,123,892 | $5.73M | |
| 2018-03-27 | — | Buy (P) | +2,123,892 | $5.73M | |
| 2018-03-27 | — | Buy (P) | +2,123,892 | $5.73M | |
| 2018-02-15 | APPN | Mixed | — | $0 | EDGAR |
| 2018-01-26 | SYNLOGIC, INC. (SYBX) Delisted | Grant (A) | +1,230,000 | $11.99M | EDGAR |
| 2017-08-30 | SYNLOGIC, INC. (SYBX) Delisted | Grant (A) | +10,183,317 | $0 | EDGAR |
| 2017-07-06 | Mersana Therapeutics, Inc. (MRSN) Delisted | Mixed | +24,420,414 | $45.00M | EDGAR |
| 2017-03-22 | MULESOFT, INC (MULE) Delisted | Mixed | −962,340 | $0 | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.